Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Euronext Alternext  >  Neovacs    ALNEV   FR0004032746

NEOVACS (ALNEV)

Delayed Quote. Delayed  - 07/22 05:35:03 pm
0.76 EUR   -1.30%
07/19 NEOVACS : and Stellar Biotechnologies Announce Launch of Neostell, J..
06/23 NEOVACS : EUR 8 million capital increase successfully completed
05/30 NEOVACS : to Present at Bio International Convention 2016
 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Euronext Alternext
07/18/2016 07/19/2016 07/20/2016 07/21/2016 07/22/2016 Date
0.76(c) 0.78(c) 0.76(c) 0.77(c) 0.76(c) Last
246 197 210 764 75 493 121 154 249 993 Volume
+2.70% +2.63% -2.56% +1.32% -1.30% Change
More quotes
Financials (€)
Sales 2016 0,10 M
EBIT 2016 -10,3 M
Net income 2016 -7,90 M
Debt 2016 4,00 M
Yield 2016 -
Sales 2017 0,10 M
EBIT 2017 4,98 M
Net income 2017 -9,90 M
Finance 2017 37,0 M
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017 1,95
EV / Sales2016 367x
EV / Sales2017 -43,5x
Capitalization 32,7 M
More Financials
Company
Neovacs SA is a biotechnology company which engages in the development of active immunotherapies for treating auto-immune, inflammatory, and cancerous diseases.It focuses on the development of Tumor Necrosis Factor-Kinoid for treating Crohn's disease and rheumatoid polyarthritis, and... 
More about the company
Latest news on NEOVACS
07/19 NEOVACS : and Stellar Biotechnologies Announce Launch of Neostell, Joint Venture..
07/19 DGAP-NEWS : Neovacs and Stellar Biotechnologies Announce Launch of Neostell, Joi..
06/23 NEOVACS : EUR 8 million capital increase successfully completed
05/30 NEOVACS : to Present at Bio International Convention 2016
05/30 NEOVACS : to Present at Bio International Convention 2016
05/30 DGAP-NEWS : Neovacs to Present at Bio International Convention 2016
05/17 DGAP-NEWS : Neovacs to attend ChinaBio(R) Event May 18 & 19, 2016
05/17 NEOVACS : to attend ChinaBio® Event May 18 & 19, 2016
05/12 NEOVACS : and Stellar Biotechnologies sign joint venture agreement to create Neo..
05/12 DGAP-NEWS : Neovacs and Stellar Biotechnologies sign a joint venture agreement t..
More news
Sector news : Biotechnology & Medical Research - NEC
07/21DJAmgen and Allergan Study Finds Biosimilar Comparable to Herceptin
07/12DJAmgen Biosimilar Gets Thumbs-Up From FDA Panel
07/12DJJuno to Resume Clinical Trial of Anticancer Treatment
07/09DJCorrections & Amplifications -- WSJ
07/08DJAMGEN : Theranos Dealt Blow as Holmes Is Banned From -2-
More sector news : Biotechnology & Medical Research - NEC
Advertisement
Chart NEOVACS
Duration : Period :
Neovacs Technical Analysis Chart | ALNEV | FR0004032746 | 4-Traders
Full-screen chart
Technical analysis trends NEOVACS
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Average target price 2,00 €
Spread / Average Target 163%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Miguel Sieler Chief Executive Officer & Director
Jean-Jacques Bertrand Chairman
Baptiste Pourtout Head-Finance
Géraldine Grouard-Vogel Chief Scientific Officer
Thérèse Croughs Chief Medical Officer
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
NEOVACS-30.08%36
INCYTE CORPORATION-20.32%16 212
CELLTRION, INC.--.--%10 689
LONZA GROUP AG11.40%9 737
QUINTILES TRANSNATIONA..7.82%8 859
ALKERMES PLC-37.26%7 528
More Results